Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06373367 · ClinicalTrials.gov registry record · NA
Preeclampsia Educational Program Study (PrEPS)
A NA study of Preeclampsia and Preeclampsia Postpartum, sponsored by MemorialCare Health System.
- Active
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06373367: Active NA study of Preeclampsia and Preeclampsia Postpartum, sponsored by MemorialCare Health System.
NCT06373367 is a NA study of Preeclampsia and Preeclampsia Postpartum that is active but no longer recruiting, run by MemorialCare Health System. The registered enrollment target is 36 participants, below the 1,125-participant average among 48 other Preeclampsia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06373367, a NA study of Preeclampsia and Preeclampsia Postpartum, is active but no longer recruiting, sponsored by MemorialCare Health System.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Preeclampsia complicates approximately 8% of all pregnancies. A critical factor of outpatient monitoring is patient education; specifically, education regarding nature of the disease, ongoing short- and long-term risks, and warning signs and symptoms for worsening of disease. This study aims to compare patient knowledge using a novel illustration based app compared to standard discharge instructions.
Primary Outcome
Short term preeclampsia knowledge score. Scored from 0-24, with 24 demonstrating the most correct answers to the assessment
Conditions Studied
Interventions
- OTHER Illustration based application
- OTHER Text based application
Study Locations (1)
California
- MemorialCare Long Beach Medical Center - Long Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What the registry record for NCT06373367 still lists
NCT06373367 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,125-participant average among 48 other Preeclampsia trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Preeclampsia appearing as the primary indexed condition, and to 2 interventions - of which Illustration based application is the first listed.
NCT06373367 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06373367 about?
NCT06373367 is a clinical study titled "Preeclampsia Educational Program Study (PrEPS)". Preeclampsia complicates approximately 8% of all pregnancies. A critical factor of outpatient monitoring is patient education; specifically, education regarding nature of the disease, ongoing short- and long-term risks, and warning signs and symptoms for worsening of disease. This study aims to comp...
What is the current status of trial NCT06373367?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2024-10-01. Estimated completion is 2026-05-31.
What conditions does trial NCT06373367 study?
This clinical trial studies the following conditions: Preeclampsia, Preeclampsia Postpartum, Preeclampsia Severe, Preeclampsia Mild.
What interventions are being tested in trial NCT06373367?
The interventions under investigation include: Illustration based application (OTHER), Text based application (OTHER).
Who is sponsoring clinical trial NCT06373367?
This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06373367 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06373367's enrollment target sits among peer trials
36 46th of 48 higher than 3 of 48 other Preeclampsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
-
Preventing Obstetric Complications With Dietary Intervention
RECRUITING · NA
-
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
RECRUITING · NA
-
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI